These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6996425)

  • 21. Long-term treatment of chronic schizophrenics with clopenthixol decanoate.
    Borsetti G; Rocco P; Spilimbergo PG; Giavedoni A; Frangiamone L; Beccaceci A; Judice A; Cisternino M; Volterra V
    Pharmatherapeutica; 1984; 4(1):53-6. PubMed ID: 6150492
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A specific method for assay of drug levels in serum of patients treated with clopenthixol decanoate injections.
    Overø KF
    Acta Psychiatr Scand Suppl; 1980; 279():92-103. PubMed ID: 6931474
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cis(Z)-clopenthixol. The neuroleptically active isomer of clopenthixol. A presentation of five double-blind clinical investigations and other studies with cis(Z)-clopenthixol (Cisordinol, Clopixol).
    Gravem A; Elgen K
    Acta Psychiatr Scand Suppl; 1981; 294():5-12. PubMed ID: 6122337
    [No Abstract]   [Full Text] [Related]  

  • 24. Cis(Z)-clopenthixol. The neuroleptically active isomer of clopenthixol. A presentation of five double-blind clinical investigations and other studies with cis(Z)-clopenthixol (Cisordinol, Clopixol).
    Acta Psychiatr Scand Suppl; 1981; 294():1-77. PubMed ID: 6122336
    [No Abstract]   [Full Text] [Related]  

  • 25. Neuroleptic treatment of oligophrenic patients. A double-blind clinical multicentre trial of cis(Z)-clopenthixol and haloperidol.
    Karsten D; Kivimäki T; Linna SL; Pollari L; Turunen S
    Acta Psychiatr Scand Suppl; 1981; 294():39-45. PubMed ID: 7041518
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A depot neuroleptic withdrawal study. A controlled study of the clinical effects of the withdrawal of depot fluphenazine decanoate and depot flupenthixol decanoate in chronic schizophrenic patients.
    Wistedt B
    Acta Psychiatr Scand; 1981 Jul; 64(1):65-84. PubMed ID: 7032224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clopentixol decanoate in the treatment of chronic alcoholism.
    Hochenegg L
    Acta Psychiatr Belg; 1981; 81(2):121-7. PubMed ID: 7293809
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A double-blind comparison of flupenthixol decanoate and fluphenazine decanoate in the treatment of chronic schizophrenia.
    Pinto R; Bannerjee A; Ghosh N
    Acta Psychiatr Scand; 1979 Oct; 60(4):313-22. PubMed ID: 390972
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clopenthixol and flupenthixol depot preparations in outpatient schizophrenics. III. Serum levels.
    Jrgensen A; Overø KF
    Acta Psychiatr Scand Suppl; 1980; 279():41-54. PubMed ID: 6931472
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dopamine and mania. The effects of trans- and cis-clopenthixol in a double-blind pilot study.
    Nolen WA
    J Affect Disord; 1983 May; 5(2):91-6. PubMed ID: 6222099
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blood and plasma kinetics of cis(Z)-clopenthixol and fluphenazine in psychiatric patients after intramuscular injection of their decanoic esters.
    Viala A; Hou N; Ba B; Durand A; Dufour H; D'Agostino N; Berda C; Jørgensen A
    Psychopharmacology (Berl); 1984; 83(2):147-50. PubMed ID: 6146995
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Depot neuroleptics in a community mental health service.
    Grant B
    Br Med J; 1979 Aug; 2(6188):501. PubMed ID: 487035
    [No Abstract]   [Full Text] [Related]  

  • 33. A 5-year follow-up study of chronic schizophrenics treated with clopenthixol decanoate.
    Carney MW
    Pharmatherapeutica; 1984; 4(1):57-63. PubMed ID: 6150493
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The positive and negative symptoms of schizophrenia: patterns of response to depot neuroleptic treatment.
    Martyns-Yellowe IS
    West Afr J Med; 1994; 13(4):200-3. PubMed ID: 7756183
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Open clinical study of cis(Z)-clopenthixol.
    Sechter D; Caillard V; Cuche H; Deniker P
    Acta Psychiatr Scand Suppl; 1981; 294():20-4. PubMed ID: 6951393
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An open clinical trial with the long-acting neuroleptic zuclopenthixol decanoate in the maintenance treatment of schizophrenia.
    Kazi HA
    Pharmatherapeutica; 1986; 4(9):555-60. PubMed ID: 3763650
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term clinical and quantitative EEG effects of clopenthixol in schizophrenics: clinical-neurophysiological correlations.
    Saletu B; Itil TM; Arat M; Akpinar S
    Int Pharmacopsychiatry; 1973; 8(4):193-207. PubMed ID: 4589638
    [No Abstract]   [Full Text] [Related]  

  • 38. Clopenthixol decanoate in the treatment of chronic schizophrenic in-patients.
    Viswanathan R; Rajhkowa S
    Pharmatherapeutica; 1982; 3(2):93-9. PubMed ID: 7100227
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Open multicentre trial of zuclopenthixol in mania and schizophrenia based on the AMDP scales.
    Bobon D; Troisfontaines B; Kempeneers JL; Xhenseval B; Bourdouxhe S; Mirel J; Gilson H; Toussaint C; von Frenckell R; Pedersen V
    Acta Psychiatr Belg; 1986; 86(2):152-76. PubMed ID: 2873713
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Monitored supportive treatment of chronic schizophrenia with delayed-action clopenthixol].
    Welbel L; Nurowska K; Szukalski B; Lipska B
    Psychiatr Pol; 1985; 19(2):109-14. PubMed ID: 4095213
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.